Evidence map›Paper›PMID 11287630›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2001

A phosphatidylinositol 3-kinase/Akt/mTOR pathway mediates and PTEN antagonizes tumor necrosis factor inhibition of insulin signaling through insulin receptor substrate-1.

O N Ozes, H Akca, L D Mayo, J A Gustin, T Maehama, J E Dixon, D B Donner

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2001. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 157 papers.

0numbers the graph read from it
0cells of the map it votes in
157citing papers in PubMed
6.7field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

157 citing papers in PubMed, 378 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Hepatocyte-SpecificNutrients · 2021
    Article
  16. Review
  17. Review
  18. Article
  19. Molecular regulation of lifespan extension in fertile ant workers.Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2021
    Article
  20. Article

97 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

O N OzesDepartment of Microbiology and Immunology, Indiana University School of Medicine and the Walther Oncology Center, Indianapolis, IN 46202, USA.
H Akca
L D Mayo
J A Gustin
T Maehama
J E Dixon
D B Donner
University of Michigan–Ann Arbor · USIndiana University – Purdue University Indianapolis · USIndiana University School of Medicine

Funding

REGULATION OF NEUROPEPTIDE BIOSYNTHESISR01DK018849 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI DIXON, JACK E, WORBY, CAROLYN ANN · 1986 to 2020
$7.0M
Tumor Necrosis Factor Action in CellsR01CA067891 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI DONNER, DAVID B · 1997 to 2006
$2.2M
VASCULAR ENDOTHELIAL CELL GROWTH FACTOR IN PATHOLOGYR01CA073023 · NCI · INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS · PI DONNER, DAVID B · 1997 to 2001
$481k
TUMOR NECROSIS FACTOR ACTION IN CELLSR55CA067891 · NCI · INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS · PI DONNER, DAVID B · 1996 to 1996
–
NCI NIH HHS CA67891NCI NIH HHS CA73023NCI NIH HHS R01 CA067891NIDDK NIH HHS DK 18849NIDDK NIH HHS R01 DK018849
6 · The paper itself

Abstract

Tyrosine phosphorylation of insulin receptor substrate-1 (IRS-1) by the insulin receptor permits this docking protein to interact with signaling proteins that promote insulin action. Serine phosphorylation uncouples IRS-1 from the insulin receptor, thereby inhibiting its tyrosine phosphorylation and insulin signaling. For this reason, there is great interest in identifying serine/threonine kinases for which IRS-1 is a substrate. Tumor necrosis factor (TNF) inhibited insulin-promoted tyrosine phosphorylation of IRS-1 and activated the Akt/protein kinase B serine-threonine kinase, a downstream target for phosphatidylinositol 3-kinase (PI 3-kinase). The effect of TNF on insulin-promoted tyrosine phosphorylation of IRS-1 was blocked by inhibition of PI 3-kinase and the PTEN tumor suppressor, which dephosphorylates the lipids that mediate PI 3-kinase functions, whereas constitutively active Akt impaired insulin-promoted IRS-1 tyrosine phosphorylation. Conversely, TNF inhibition of IRS-1 tyrosine phosphorylation was blocked by kinase dead Akt. Inhibition of IRS-1 tyrosine phosphorylation by TNF was blocked by rapamycin, an inhibitor of the mammalian target of rapamycin (mTOR), a downstream target of Akt. mTOR induced the serine phosphorylation of IRS-1 (Ser-636/639), and such phosphorylation was inhibited by rapamycin. These results suggest that TNF impairs insulin signaling through IRS-1 by activation of a PI 3-kinase/Akt/mTOR pathway, which is antagonized by PTEN.

Indexed as

Protein KinasesProtein Serine-Threonine KinasesSignal TransductionTumor Suppressor ProteinsAmino Acid SequenceCell LineChromatography, LiquidHumansInsulinInsulin Receptor Substrate ProteinsInsulin ResistanceMolecular Sequence DataPhosphatidylinositol 3-KinasesPhosphoproteinsPhosphoric Monoester HydrolasesPhosphorylationAKT1 protein, humanInsulinInsulin Receptor Substrate ProteinsIRS1 protein, humanMTOR protein, humanPhosphatidylinositol 3-KinasesPhosphoproteinsPhosphoric Monoester HydrolasesPhosphotransferases (Alcohol Group Acceptor)Protein KinasesProtein Serine-Threonine KinasesProto-Oncogene ProteinsProto-Oncogene Proteins c-aktPTEN PhosphohydrolasePTEN protein, humanTOR Serine-Threonine KinasesTumor Necrosis Factor-alphaTumor Suppressor ProteinsTyrosine

Identifiers

PMID11287630
PMCPMC31887
OpenAlexW2033996868

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.